gsoilis.bsky.social
@gsoilis.bsky.social
Ampicillin/Sulbactam in Combination with Ceftazidime/Avibactam against Metallo-ß-Lactamase-Producing Carbapenem-Resistant Acinetobacter baumannii: A Genomics-Informed Mechanism-Based Model

✅ Just Accepted
🔗 https://bit.ly/3WUrcmU
November 15, 2025 at 1:12 AM
Potential health and cost impacts of a point-of-care test for neonatal sepsis and possible serious bacterial infections in infants: a modeling analysis in two settings

✅ Just Accepted
🔗 https://bit.ly/4nDR2q4
November 6, 2025 at 7:34 PM
Maternal, pregnancy and infant outcomes in women treated for multidrug/rifampicin-resistant tuberculosis with novel and repurposed drugs in KwaZulu-Natal, South Africa

✅ Just Accepted
🔗 https://bit.ly/3JhtYzq
November 6, 2025 at 7:33 PM
Trends in Persons Prescribed HIV Postexposure Prophylaxis in the United States, 2015?2023

✅ Just Accepted
#IDSky
🔗 https://bit.ly/48IyEIL
October 31, 2025 at 2:06 AM
Insights into the Role of Rifampicin Exposure and Clinical Baseline Covariates on the Response to Pulmonary Tuberculosis Treatment

✅ Just Accepted
#IDSky
🔗 https://bit.ly/3Ws4x0Q
October 31, 2025 at 2:03 AM
who.int WHO @who.int · Oct 20
Fiji makes history!
In a landmark public health achievement, Fiji has been validated by WHO for eliminating trachoma as a public health problem.

✅ Trachoma — a neglected tropical disease (NTD) and the world’s leading infectious cause of blindness — is the first NTD to be eliminated in Fiji.
October 23, 2025 at 6:54 PM
Do Aminopenicillins Have a Role in Treating Ampicillin-Resistant Enterococcus UTIs?

✅ Just Accepted
#IDSky
🔗 https://bit.ly/46QolRz
October 23, 2025 at 6:52 PM
who.int WHO @who.int · Oct 14
New WHO report finds 1 in 6 bacterial infections were resistant to antibiotic treatments.

Data from over 100 countries warns that rising resistance to essential antibiotics poses a growing threat to global health.

Read more 👉bit.ly/438Ta1u
October 14, 2025 at 4:54 PM
This is concerning given the lack of new antibiotics in the development process! #PITT_IDFall25
Carbapenemase producing Carbapenem-Resistant Enterobacterales are a growing threat in UK, associated with mortality and cost. This review synthesises evidence in prevalence of CP-CRE in healthcare & community settings
https://www.journalofhospitalinfection.com/article/S0195-6701(25)00249-X/fulltext
October 14, 2025 at 4:54 PM
The Changing Paradigm in Infectious Diseases - Host-Directed Medicine: Implications for the Next Generation of ID Physicians

✅ Just Accepted
#IDSky
🔗 https://bit.ly/4nrIwey
September 30, 2025 at 11:56 PM
Reassessing Adherence Trajectories in Multidrug-Resistant Tuberculosis: Recovery Advantage and Hidden Biases

✅ Just Accepted
#IDSky
🔗 https://bit.ly/3W8Fb7U
September 30, 2025 at 11:56 PM
Risk of Post-COVID Conditions among adolescents and adults who received nirmatrelvir-ritonavir for acute COVID-19: a retrospective cohort study

✅ Just Accepted
#IDSky
🔗 https://bit.ly/3Kx8oa2
September 23, 2025 at 8:19 PM
It's interesting to see how quickly AI is evolving! #PITT_IDFall25
The role of AI in infectious diseases is emerging—offering new opportunities for infection prevention, outbreak detection & control.

But challenges like data fragmentation & trust remain.

Explore a new @thelancetinfdis.bsky.social Series ⤵️
bit.ly/4nbkHrh
September 17, 2025 at 6:05 PM
Great read especially since we're heading into cold/flu/COVID season! COVID-19 continues to be a disease burden in the community setting! #PITT_IDFall25
September 17, 2025 at 6:04 PM
Very informative article! I didn't know small-molecule antivirals could be used to control epidemics and pandemics! #PITT_IDFall25
September 9, 2025 at 4:45 PM
April 22, 2025 at 9:53 PM
Potential first new antibiotic for gonorrhoea since the 1990s is effective and safe, finds trial.

Explore the research ➡️ tinyurl.com/5bu2nbyt #ESCMID #ESCMIDGlobal
April 15, 2025 at 5:19 PM
April 8, 2025 at 6:03 PM